Larry W Moreland

Larry W Moreland

UNVERIFIED PROFILE

Are you Larry W Moreland?   Register this Author

Register author
Larry W Moreland

Larry W Moreland

Publications by authors named "Larry W Moreland"

Are you Larry W Moreland?   Register this Author

100Publications

2870Reads

23Profile Views

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis.

J Rheumatol 2019 Sep 1. Epub 2019 Sep 1.

From Boston University, Boston, MA, USA; University of Arizona, Tucson, AZ, USA; University of Michigan, Ann Arbor, MI, USA; University of South Florida, Tampa, FL, USA; Mount Sinai Hospital, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; University of Utah, Salt Lake City, UT, USA; Cleveland Clinic, Cleveland, OH, USA; University of Pennsylvania, Philadelphia, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA; Johns Hopkins University, Baltimore, MD, USA; Mayo Clinic, Rochester, MN, USA; VA Boston Healthcare System, Boston, MA, USA. This work was sponsored by the Vasculitis Clinical Research Consortium. The Vasculitis Clinical Research Consortium (VCRC) is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS). The VCRC is funded through collaboration between NCATS, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), U54 AR057319), and has received funding from the National Center for Research Resources (U54 RR019497). Additional funding for this project included RC1 AR 058303 and P60 AR047785. Dr. Merkel reports receiving funds for the following activities: Consulting: AbbVie, AstraZeneca, Biogen, Boeringher-Ingelheim, Bristol-Myers Squibb, Celgene, ChemoCentryx, Genentech/Roche, Genzyme/Sanofi, GlaxoSmithKline, InflaRx, Insmed, Jannsen, Kiniksa; Research Support: AstraZeneca, Boeringher- Ingelheim, Bristol-Myers Squibb, Celgene, ChemoCentryx, Genentech/Roche, GlaxoSmithKline, Kypha, TerumoBCT; Royalties: UpToDate. Dr. Monach reports receiving funds for the following activities: Consulting: Celgene, ChemoCentryx. Address correspondence to Paul Monach, MD, PhD Rheumatology Section VA Boston Healthcare System 150 South Huntington Ave Boston, MA 02130. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190093DOI Listing
September 2019

Inflammatory joint diseases and atherosclerosis: time to look beyond the 'lipid paradox'.

Curr Opin Lipidol 2019 Aug;30(4):342-349

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000620DOI Listing
August 2019

Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases.

Rheum Dis Clin North Am 2018 Aug 12;44(3):475-487. Epub 2018 Jun 12.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, 3500 Terrace Street, Thomas E. Starzl Biomedical Science Tower South 711, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2018.03.006DOI Listing
August 2018

14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T2 and CD8 lymphocytes from patients with scleroderma.

J Allergy Clin Immunol 2018 07 15;142(1):109-119.e6. Epub 2017 Nov 15.

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.10.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953767PMC
July 2018

Cardiovascular Disease Risk in Patients with Rheumatic Diseases.

Clin Geriatr Med 2017 02;33(1):105-117

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, 3500 Terrace Street, Thomas E. Starzl Biomedical Science Tower South 711, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cger.2016.08.008DOI Listing
February 2017

Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.

Arthritis Care Res (Hoboken) 2016 12 21;68(12):1751-1757. Epub 2016 Oct 21.

University of Nebraska Medical Center, Omaha, and National Data Bank for Rheumatic Diseases, Wichita, Kansas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22895DOI Listing
December 2016

Analysis of CXCR5Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis.

Sci Rep 2016 12 22;6:39474. Epub 2016 Dec 22.

Division of Rheumatology, Department of Medicine, University of Pittsburgh, 3500 Terrace St, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep39474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177940PMC
December 2016

Reply.

Arthritis Rheumatol 2016 Feb;68(2):555-6

University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39471DOI Listing
February 2016

Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene.

PLoS One 2014 10;9(2):e87645. Epub 2014 Feb 10.

Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America ; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America ; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087645PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919745PMC
October 2014

Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritis.

Curr Rheumatol Rep 2014 May;16(5):417

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, S703 Biomedical Science Tower, 3500 Terrace Street, Pittsburgh, PA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-014-0417-8DOI Listing
May 2014

Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Nature 2014 Feb 25;506(7488):376-81. Epub 2013 Dec 25.

1] Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. [2] Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. [3] Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944098PMC
February 2014

Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.

J Rheumatol 2013 Nov 15;40(11):1812-22. Epub 2013 Aug 15.

From the University of Alabama at Birmingham, Birmingham, Alabama; Emory University, Atlanta, Georgia; The University of North Carolina, Chapel Hill, North Carolina; The Medical University of South Carolina, Charleston, South Carolina; Washington University at St. Louis, St. Louis, Missouri; The University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987124PMC
November 2013

Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis.

J Rheumatol 2013 Sep 15;40(9):1498-504. Epub 2013 Jun 15.

Departments of Medicine and Biostatistics, Omaha Veterans Affairs Medical Center (VAMC) and University of Nebraska Medical Center, Omaha, Nebraska 68198-6270, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026220PMC
September 2013

JAK inhibition in rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):379-80

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0196-4DOI Listing
October 2011

Inhibition of spleen tyrosine kinase for rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):377-8

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0195-5DOI Listing
October 2011

Cost-effectiveness of biologics compared with disease-modifying antirheumatic drugs in rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):381-2

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0197-3DOI Listing
October 2011

Certolizumab pegol: a new biologic targeting rheumatoid arthritis.

Expert Rev Clin Immunol 2010 Nov;6(6):855-66

Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children's Hospital, Suite 3000, 400 45th Street, Pittsburgh, PA 15201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.10.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971417PMC
November 2010

Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

Drug Des Devel Ther 2010 Oct 1;4:263-78. Epub 2010 Oct 1.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S14099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990387PMC
October 2010

Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis.

J Rheumatol 2010 Feb 23;37(2):275-81. Epub 2009 Dec 23.

University of Nebraska Medical Center, Nebraska Arthritis Outcomes Research Center (NAORC), Omaha Veterans Affairs Medical Center, Omaha, Nebraska 68198-6270, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133625PMC
February 2010

Cytokines as targets for anti-inflammatory agents.

Authors:
Larry W Moreland

Ann N Y Acad Sci 2009 Dec;1182:88-96

University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2009.05072.xDOI Listing
December 2009

Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms.

Semin Arthritis Rheum 2009 Oct 3;39(2):132-43. Epub 2008 Dec 3.

University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2008.08.003DOI Listing
October 2009

Methotrexate versus combination methotrexate and etanercept for rheumatoid arthritis.

Curr Rheumatol Rep 2009 Oct;11(5):309-10

Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children's Hospital, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741098PMC
October 2009

Certolizumab pegol in active rheumatoid arthritis.

Curr Rheumatol Rep 2009 Oct;11(5):311-2

Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children's Hospital, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741093PMC
October 2009

Tocilizumab versus methotrexate in moderate to severe rheumatoid arthritis.

Curr Rheumatol Rep 2009 Oct;11(5):313-4

Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology, University of Pittsburgh, Children's Hospital, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741095PMC
October 2009

Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.

Clin Infect Dis 2009 Sep;49(6):924-7

Division of Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/605498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315107PMC
September 2009

Disease modifiers: making the right therapeutic choices for our patients.

Authors:
Larry W Moreland

J Rheumatol Suppl 2007 Jul;79:21-6

Department of Internal Medicine, University of Alabama, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
July 2007

Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.

Arthritis Rheum 2007 Apr;56(4):1051-66

University of Alabama at Birmingham, Department of Medicine 35294-3408, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.22489DOI Listing
April 2007

Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis.

J Rheumatol 2006 Nov 1;33(11):2162-6. Epub 2006 Oct 1.

Division of Rheumatology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., B-131, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
November 2006

Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.

J Rheumatol 2006 May 15;33(5):854-61. Epub 2006 Mar 15.

Clinical Immunology and Rheumatology,University of Alabama at Birmingham, Birmingham, AL 35294-7201, USA.

View Article

Download full-text PDF

Source
May 2006

Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.

J Rheumatol 2006 Apr 15;33(4):659-64. Epub 2006 Feb 15.

Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
April 2006

Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis.

Arthritis Rheum 2006 Apr;55(2):287-93

University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21838DOI Listing
April 2006

Febuxostat--treatment for hyperuricemia and gout?

Authors:
Larry W Moreland

N Engl J Med 2005 Dec;353(23):2505-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe058247DOI Listing
December 2005

Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.

Expert Opin Biol Ther 2005 Sep;5(9):1245-54

Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama, 1717 6th Ave South, Birmingham, AL 35294-7201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.5.9.1245 DOI Listing
September 2005

Biologic therapies on the horizon for rheumatoid arthritis.

Authors:
Larry W Moreland

J Clin Rheumatol 2004 Jun;10(3 Suppl):S32-9

From the University of Alabama at Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.rhu.0000130688.68036.efDOI Listing
June 2004